Bank of Montreal’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,500
Closed -$10.3M 3644
2025
Q1
$10.3M Buy
+12,500
New +$10.4M 0.01% 916
2023
Q3
Sell
-25,000
Closed -$11.7M 4045
2023
Q2
$11.7M Buy
+25,000
New +$10.5M ﹤0.01% 952
2022
Q4
Sell
-400
Closed -$132 4160
2022
Q3
$132 Buy
+400
New +$127K ﹤0.01% 3366
2019
Q2
Sell
-12,500
Closed -$1.62M 4989
2019
Q1
$1.62M Buy
12,500
+3,400
+37% +$413K ﹤0.01% 1793
2018
Q4
$1.05M Buy
+9,100
New +$1.02M ﹤0.01% 1863
2014
Q1
Sell
-700
Closed -$36K 4081
2013
Q4
$36K Hold
700
﹤0.01% 3000
2013
Q3
$35K Hold
700
﹤0.01% 2984
2013
Q2
$34K Buy
+700
New +$38.1K ﹤0.01% 2866

Other funds holding LLY

Bank of Montreal's LLY Position: Q1 2026 in Review

Bank of Montreal reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $124M and leaving 1,507,369 shares worth $1.39B. The position accounts for 0.52% of the portfolio, ranked #38.

Bank of Montreal first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.75B in Q4 2025. 4,364 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of Montreal held 1,507,369 shares of Eli Lilly worth $1.39B as of Q1 2026.
  • Bank of Montreal sold 122,082 Eli Lilly shares in Q1 2026, an estimated $124M.
  • Eli Lilly made up 0.52% of Bank of Montreal's portfolio in Q1 2026, its #38 holding.
  • Bank of Montreal first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Eli Lilly position peaked at $1.75B in Q4 2025.
  • 4,364 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.